Lutronic AccuSculpt
Laser lipolysis (internal) · 1444nm laser lipolysis
New Lutronic AccuSculpt pricing is not published; used and refurbished systems trade around $8k–$20k. Lutronic AccuSculpt holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.
What it's actually cleared for: 1444nm laser lipolysis (US clearance is AccuSculpt II)
Last verified: August 6, 2026 · How we verify
New: —|Used: $8k–$20kmarket estimate, no email required
| Manufacturer | Lutronic |
|---|---|
| Company | Owner: Hahn & Company (South Korean private equity) (private equity owned, since 2024) · Distribution: direct |
| Category | Body Contouring |
| Technology | 1444nm laser lipolysis |
| FDA status | FDA Cleared |
| New price range | Not published |
| Used price range | $8k–$20k |
| Consumables | Not published |
| Launch year | 2010 |
| Last verified | August 6, 2026 |
Overview
1444nm high fat affinity; also marketed for facial AccuLift
FDA & regulatory status
What it's actually cleared for:
1444nm laser lipolysis (US clearance is AccuSculpt II)
510(k) numbers
K101573
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Recent industry events
How we source company dataOwnership and corporate changes at Lutronic that can affect warranty, service and parts availability.
- Jan 2024
Cynosure and Lutronic merge under Hahn & Company
MergerCynosure and Lutronic announced their merger on January 19, 2024, closing later that year to form Cynosure Lutronic, Inc. under South Korean private equity firm Hahn & Company; terms undisclosed. This followed CD&R's 2019 purchase of Cynosure from Hologic for $205M and Hahn's 2023 acquisition of Lutronic.
Source: PR Newswire (Jan 19, 2024); Hologic filings
Treatment economics
Economics data for this platform hasn't been published yet.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 5, 2026
FDA status
Unknown → Cleared
Source: Automatic record update
August 5, 2026
FDA K-numbers
K101573
Source: Automatic record update
August 5, 2026
FDA indication
1444nm laser lipolysis (US clearance is AccuSculpt II)
Source: Automatic record update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.